drugset / Trial / NCT04601883

Colchicine as Treatment for People With Hand Osteoarthritis

NCT04601883

Phase 4 Completed 100 enrolled Henning Bliddal
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aims to compare oral colchicine 0.5 mg administered two times daily for 12 weeks with placebo as a treatment of hand OA symptoms.

Timeline

Start
2021-01-15
Primary completion
2022-08-03
Completion
2022-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg Oral

Indications